Please assess the completion status of the following clinical trial:

Trial Title: ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject has provided informed consent.~2. Subject is ≥ 18 years of age at the time of consent.~3. Subject will be undergoing an elective midline laparotomy.~4. Subject may have a combination of low- and high-risk factors but cannot exceed a total of 5 risk factors or have more than 2 high-risk factors. Subject must have at least 2 low-risk factors if subject does not have any high-risk factors. High- and low-risk factors include:~   1. High-Risk Factors (maximum of 2): i.BMI≥ 35; ii.Prior open abdominal surgery; iii.Daily active smoker or Chronic Obstructive Pulmonary disease (COPD) diagnosis; iv. Current or recent (within 1 year) cancer diagnosis or chemotherapy treatment; v.History of or current abdominal aorta aneurism or surgery for abdominal aortaaneurism~  2. Low-Risk Factors (minimum of 2, if no high-risk factors): i.25 ≤ BMI \< 35; ii.Age \> 45; iii.Uncontrolled diabetes; iv.Malnutrition as defined by 10% weight loss within the last 3 months; v.Current immunosuppressive treatment; vi.Undergoing colorectal surgery~Exclusion Criteria:~1. Subject is undergoing emergency surgery, i.e. lifesaving procedures performed where subject is in imminent danger of death.~2. Subject for which the device is used outside the product IFU, including;~   1. Pregnant women: Women who are known or suspected to be pregnant, or who are planning to become pregnant during the study follow-up period~  2. Subject who has an infection within 30 days of enrollment or, at the time of the surgery, has any active, acute or chronic infection(s) that are uncontrolled and/or requiring treatment such as antibiotics~  3. Subject whose surgical site is contaminated or dirty/infected intraoperatively, as assessed by the Investigator (Exclude Altemeier classification III-IV).~3. Subject who had received a mesh in a previous ventral hernia repair or has a ventral hernia.~4. Investigator determined that a planned future surgery would interfere with application of mesh reinforcement.~5. Subject has participated in an investigational drug or device research study within 30 days of enrollment.~6. Subject has a life expectancy of \<2 years.~7. Subject has an ASA Physical Status Classification System score \>3.~8. Subject has \>5 total risk factors or \>2 high-risk factors

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hernia prevention cohort (Type: OTHER): single arm safety study, no control arm

Based on this trial design, predict the completion outcome and termination type (if applicable).